Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136390979> ?p ?o ?g. }
- W3136390979 endingPage "434.e3" @default.
- W3136390979 startingPage "423" @default.
- W3136390979 abstract "Cancer immunotherapy is associated with several immune-related adverse events, but the relationship between immunotherapy and venous thromboembolism has not been thoroughly studied.We conducted a retrospective cohort study of 1,686 patients who received immunotherapy for a variety of malignancies to determine the incidence of venous thromboembolism and the impact of venous thromboembolism on survival. To examine the potential role of inflammation in venous thromboembolism, we also profiled immune cells and plasma cytokines in blood samples obtained prior to initiation of immunotherapy in a sub-cohort of patients treated on clinical trials who subsequently did (N = 15), or did not (N = 10) develop venous thromboembolism.Venous thromboembolism occurred while on immunotherapy in 404/1686 patients (24%) and was associated with decreased overall survival [HR=1.22 (95% CI 1.06-1.41), p<0.008]. Patients that developed venous thromboembolism had significantly higher pretreatment levels of myeloid-derived suppressor cells (5.382 ± 0.873 vs. 3.341 ± 0.3402, mean ± SEM; p=0.0045), interleukin 8 (221.2 ± 37.53 vs. 111.6 ± 25.36, mean ± SEM; p=0.016), and soluble vascular cell adhesion protein 1 (1210 ± 120.6 vs. 895.5 ± 53.34, mean ± SEM; p=0.0385).These findings demonstrate that venous thromboembolism is an underappreciated and important immune-related adverse event associated with cancer immunotherapy, and may implicate an interleukin 8 and myeloid-derived suppressor cell-driven pathway in pathogenesis." @default.
- W3136390979 created "2021-03-29" @default.
- W3136390979 creator A5002744671 @default.
- W3136390979 creator A5005282856 @default.
- W3136390979 creator A5008954779 @default.
- W3136390979 creator A5014253368 @default.
- W3136390979 creator A5023438864 @default.
- W3136390979 creator A5025216603 @default.
- W3136390979 creator A5026865748 @default.
- W3136390979 creator A5029518726 @default.
- W3136390979 creator A5035031332 @default.
- W3136390979 creator A5039576853 @default.
- W3136390979 creator A5044873389 @default.
- W3136390979 creator A5057402683 @default.
- W3136390979 creator A5062592912 @default.
- W3136390979 creator A5067833462 @default.
- W3136390979 creator A5079075086 @default.
- W3136390979 creator A5089136921 @default.
- W3136390979 creator A5090375120 @default.
- W3136390979 date "2021-04-01" @default.
- W3136390979 modified "2023-10-18" @default.
- W3136390979 title "Increased incidence of venous thromboembolism with cancer immunotherapy" @default.
- W3136390979 cites W1584365424 @default.
- W3136390979 cites W1696065146 @default.
- W3136390979 cites W1922412259 @default.
- W3136390979 cites W1966329335 @default.
- W3136390979 cites W1978080273 @default.
- W3136390979 cites W1996600303 @default.
- W3136390979 cites W200550325 @default.
- W3136390979 cites W2013996375 @default.
- W3136390979 cites W2016904909 @default.
- W3136390979 cites W2019108205 @default.
- W3136390979 cites W2025544236 @default.
- W3136390979 cites W2026878412 @default.
- W3136390979 cites W2028673858 @default.
- W3136390979 cites W2033577259 @default.
- W3136390979 cites W2038981426 @default.
- W3136390979 cites W2042452452 @default.
- W3136390979 cites W2049017883 @default.
- W3136390979 cites W2050624503 @default.
- W3136390979 cites W2088096858 @default.
- W3136390979 cites W2097131595 @default.
- W3136390979 cites W2139657244 @default.
- W3136390979 cites W2147618390 @default.
- W3136390979 cites W2154889421 @default.
- W3136390979 cites W2172537925 @default.
- W3136390979 cites W2259176485 @default.
- W3136390979 cites W2263759961 @default.
- W3136390979 cites W2265285917 @default.
- W3136390979 cites W2298626553 @default.
- W3136390979 cites W2342473733 @default.
- W3136390979 cites W2510989807 @default.
- W3136390979 cites W2541189331 @default.
- W3136390979 cites W2543049646 @default.
- W3136390979 cites W2568946517 @default.
- W3136390979 cites W2750319320 @default.
- W3136390979 cites W2759963646 @default.
- W3136390979 cites W2783137027 @default.
- W3136390979 cites W2791483720 @default.
- W3136390979 cites W2797684906 @default.
- W3136390979 cites W2803640001 @default.
- W3136390979 cites W2806358230 @default.
- W3136390979 cites W2886331090 @default.
- W3136390979 cites W2889317689 @default.
- W3136390979 cites W2890257935 @default.
- W3136390979 cites W2891269224 @default.
- W3136390979 cites W2892952396 @default.
- W3136390979 cites W2897684680 @default.
- W3136390979 cites W2898022640 @default.
- W3136390979 cites W2902078827 @default.
- W3136390979 cites W2904564310 @default.
- W3136390979 cites W2911093128 @default.
- W3136390979 cites W2912725678 @default.
- W3136390979 cites W2915087712 @default.
- W3136390979 cites W2915629824 @default.
- W3136390979 cites W2917722773 @default.
- W3136390979 cites W2946261461 @default.
- W3136390979 cites W2948155539 @default.
- W3136390979 cites W2955241712 @default.
- W3136390979 cites W2964286623 @default.
- W3136390979 cites W2971507604 @default.
- W3136390979 cites W2973378377 @default.
- W3136390979 cites W2988124258 @default.
- W3136390979 cites W2996181407 @default.
- W3136390979 cites W2996270284 @default.
- W3136390979 cites W3020886383 @default.
- W3136390979 cites W3021646013 @default.
- W3136390979 cites W3035628474 @default.
- W3136390979 cites W3037020655 @default.
- W3136390979 cites W3038573540 @default.
- W3136390979 cites W3043690500 @default.
- W3136390979 cites W3092857774 @default.
- W3136390979 cites W4211218985 @default.
- W3136390979 cites W4243127788 @default.
- W3136390979 doi "https://doi.org/10.1016/j.medj.2021.02.002" @default.
- W3136390979 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8143033" @default.
- W3136390979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34036293" @default.
- W3136390979 hasPublicationYear "2021" @default.